Summary of the new price submission process in Germany following the 2010 healthcare reforms. An article by European pharmaceutal market access expert, Nigel Seear of Bridgehead International.
Commentary on the recent pharmaceutical reforms in Spain by Nigel Seear, pharmaceutical market access specialist, Bridgehead International
Reforms in the French healthcare system following on from the drug safety scandal
Faced with the massive challenge of attempting to ensure a steady and strong growth in sales and profit from a…
Intellectual Property of one form or another is a key component of the value of almost all businesses. In the…
